AC
EW icon

AlphaCore Capital’s Edwards Lifesciences EW Stock Holding History

AlphaCore Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
6,163
+2,741
+80% +$230K 0.01% 641
2026
Q1 		$274K Sell
3,422
-3,323
-49% -$274K 0.01% 717
2025
Q4 		$575K Buy
6,745
+2,131
+46% +$175K 0.01% 576
2025
Q3 		$359K Buy
4,614
+2,535
+122% +$198K 0.01% 542
2025
Q2 		$163K Buy
+2,079
New +$155K 0.01% 623
2020
Q2 		– Sell
-204
Closed -$13K – 154
2020
Q1 		$13K Buy
+204
New +$14.7K 0.01% 188

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

AlphaCore Capital's EW Position: Q2 2026 in Review

AlphaCore Capital increased its Edwards Lifesciences (EW) stake by 80% in Q2 2026, buying an estimated $230K and bringing the position to 6,163 shares worth $558K. The position accounts for 0.01% of the portfolio, ranked #641.

AlphaCore Capital first reported a position in EW in Q1 2020 and has held it in 6 quarters since. The position peaked at $575K in Q4 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • AlphaCore Capital held 6,163 shares of Edwards Lifesciences worth $558K as of Q2 2026.
  • AlphaCore Capital bought 2,741 Edwards Lifesciences shares in Q2 2026, an estimated $230K.
  • Edwards Lifesciences made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #641 holding.
  • AlphaCore Capital first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 6 quarters since.
  • AlphaCore Capital's Edwards Lifesciences position peaked at $575K in Q4 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.